Compare IQV & SOFI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | IQV | SOFI |
|---|---|---|
| Founded | 1982 | 2011 |
| Country | United States | United States |
| Employees | 93000 | N/A |
| Industry | Biotechnology: Commercial Physical & Biological Resarch | Diversified Financial Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 28.6B | 33.4B |
| IPO Year | 2013 | 2020 |
| Metric | IQV | SOFI |
|---|---|---|
| Price | $156.40 | $16.53 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 16 | 16 |
| Target Price | ★ $227.13 | $24.43 |
| AVG Volume (30 Days) | 1.3M | ★ 53.9M |
| Earning Date | 05-05-2026 | 04-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 4.67 | N/A |
| EPS | ★ 7.84 | 0.39 |
| Revenue | ★ $9,739,000,000.00 | $619,353,000.00 |
| Revenue This Year | $6.77 | $32.54 |
| Revenue Next Year | $5.89 | $21.82 |
| P/E Ratio | ★ $20.30 | $41.09 |
| Revenue Growth | ★ 41.60 | 23.10 |
| 52 Week Low | $134.65 | $12.44 |
| 52 Week High | $247.05 | $32.73 |
| Indicator | IQV | SOFI |
|---|---|---|
| Relative Strength Index (RSI) | 35.92 | 42.53 |
| Support Level | N/A | $14.93 |
| Resistance Level | $193.26 | $19.81 |
| Average True Range (ATR) | 5.68 | 0.77 |
| MACD | -1.59 | -0.21 |
| Stochastic Oscillator | 7.16 | 21.80 |
Iqvia is a global leader in clinical research and technology solutions for the life science industry. Formed in 2016 from the merger of Quintiles and IMS Health, it combined clinical trial services with extensive healthcare data and analytics. Its reserach and development solutions segment provides outsourced clinical development services spanning drug discovery, trial design, patient recruitment, site management, clinical testing, real-world studies, and the regulatory approval process. Its commercial solutions segment helps companies optimize product commercialization through analytics, technology, and outsourced sales and medical services. Together, Iqvia supports customers across the life science industry, and it serves biopharmaceutical firms, providers, payers, and policymakers.
SoFi is a financial-services company that was founded in 2011 and is based in San Francisco. Initially known for its student loan refinancing business, the company has expanded its product offerings to include personal loans, credit cards, mortgages, investment accounts, banking services, and financial planning. The company intends to be a one-stop shop for its clients' finances and operates solely through its mobile app and website. Through its acquisition of Galileo in 2020, the company also offers payment and account services for debit cards and digital banking.